Eur Rev Med Pharmacol Sci 2020; 24 (22): 11461-11461
DOI: 10.26355/eurrev_202011_23745

Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity

P.-F. Su, S.-Q. Song

Department of Neurosurgery, The Fifth Affiliated Hospital of Harbin Medical University, Daqing, Heilongjiang, China.

 

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity, by P.-F. Su, S.-Q. Song, published in Eur Rev Med Pharmacol Sci 2018; 22 (20): 6864-6872–DOI: 10.26355/eurrev_201810_16155–PMID: 30402851” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/16155

Free PDF Download

To cite this article

P.-F. Su, S.-Q. Song
Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11461-11461
DOI: 10.26355/eurrev_202011_23745

Keywords Related articles:

  1. Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity
  2. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR
  3. MiR-205 enhances cisplatin sensitivity of glioma cells by targeting E2F1
  4. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR
  5. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis